Viz.ai stroke wedge to enterprise care coordination

Viz.ai is using stroke as the wedge to become a hospital wide care coordination layer, not just a single imaging tool. Stroke gives it the easiest place to prove hard ROI, because every minute saved matters clinically and financially, then that proof helps it sell more algorithms into the same radiology feeds, EHR workflows, and physician messaging network across cardiology, pulmonary, and oncology use cases.1 2 3 4 5

• The initial stroke sale is concrete and measurable. Viz.ai built early fit around large vessel occlusion detection from CT scans and care team alerts, with published real world data showing faster detection, faster transfer, and higher thrombectomy volumes. CMS reimbursement also made the first department level purchase easier to justify.1 4 6
• Expansion works because the buyer does not need a new system each time. Once a hospital has Viz.ai connected to scanners, EHR data, and clinician communication flows, adding pulmonary embolism, hypertrophic cardiomyopathy, or oncology workflows is closer to turning on another module than running a fresh enterprise deployment.1 2 5 7
• This same installed network now supports a second business line with pharma and device companies. Viz.ai had 10 life sciences partnerships as of January 7, 2025, then 13 by January 12, 2026, and its partner page now lists 14, showing how hospital workflow distribution became something outside companies will also pay to access.3 8 9

The next step is a broader disease specific workflow suite inside the same hospital footprint. As Viz.ai approaches 2,000 hospitals and adds more care pathways, the center of gravity shifts from selling point algorithms to owning how urgent patients are identified, routed, and matched to treatment across the enterprise.3 5 7